Can science finally outpace one of the rarest and most aggressive forms of skin lymphoma? Sézary syndrome, a subtype of cutaneous T-cell lymphoma, has long frustrated oncologists due to its elusive nature and limited treatment options. But thanks to medical breakthroughs and increased attention from biotech companies, the Sézary Syndrome Treatment Market is showing signs of major...